Markus Teige

Title: Innovations of Markus Teige in Biotechnology

Introduction

Markus Teige is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequences and proteins. His work focuses on the development of polypeptides that have important applications in diagnosis and therapy.

Latest Patents

Markus Teige holds a patent for a "Nucleic acid sequence and protein in addition to polypeptides coding for mannitol dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy." This invention relates to polypeptides made of mannitol dehydrogenase and nucleic acids coding for these polypeptides, emphasizing their use in medical diagnostics and therapeutic applications. He has 1 patent to his name.

Career Highlights

Teige is currently associated with Biomay Produktions- und Handelsaktiengesellschaft, a company that specializes in biotechnology and the production of enzymes. His role at Biomay has allowed him to further his research and development efforts in the field.

Collaborations

Throughout his career, Markus has collaborated with several professionals, including Birgit Simon-Nobbe and Peter Schneider. These collaborations have enhanced his research and contributed to the advancement of biotechnology.

Conclusion

Markus Teige's innovative work in biotechnology, particularly in the development of mannitol dehydrogenases, showcases his commitment to advancing medical science. His contributions are significant in the realm of diagnostics and therapy, marking him as a key figure in his field.